Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-249265
Filing Date
2022-09-22
Accepted
2022-09-22 17:02:00
Documents
2
Group Members
ICG FMC LTDICG LIFE SCIENCES GP LP SCSPICG LIFE SCIENCES GP S.A.R.LINTERMEDIATE CAPITAL GROUP PLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d360719dsc13g.htm SC 13G 116730
2 EX-99.1 d360719dex991.htm EX-99.1 7953
  Complete submission text file 0001193125-22-249265.txt   126438
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 425-276-2300
Eliem Therapeutics, Inc. (Subject) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92797 | Film No.: 221259982
SIC: 2834 Pharmaceutical Preparations

Mailing Address PRIVATE BUSINESS CENTER 32-36 BOULEVARD D'AVRANCHES LUXEMBOURG N4 L-1160
Business Address PRIVATE BUSINESS CENTER 32-36 BOULEVARD D'AVRANCHES LUXEMBOURG N4 L-1160 352 20 88 21 40
ICG Life Sciences SCSp (Filed by) CIK: 0001926450 (see all company filings)

EIN.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 0331
Type: SC 13G